- POSTED: 02 Oct 2013 14:48
This graph is an experimental feature that tracks number of views over time.
A mobile application has been developed to help patients with type 2 diabetes overcome the problem of not knowing how much insulin to inject at the right time.
SINGAPORE: A mobile application has been developed to help patients with type 2 diabetes overcome the problem of not knowing how much insulin to inject at the right time.
Thus, "SGH Diabetes Pal" was developed by Singapore General Hospital and Integrated Health Information Systems. The app informs users of the required dosage of insulin based on the fasting blood sugar reading they input every morning.
Patients using the app have to test their blood sugar level every morning and key in the reading.
Based on the data entered and the patients' prescribed treatment plan, the app will prompt them on the dosage of the insulin injection they need to administer to achieve optimum blood sugar levels.
The app also generates graphs from the daily readings, so patients can easily see their progress in managing their diabetes.
An administration function also allows doctors to monitor their patients progress online so they can intervene if needed.
There are also safety features on the app, such as a preset maximum dose of insulin based on the patient's body weight. The patient can also set his mobile app to remind him daily to test his blood sugar level and to enter the readings into the smartphone.
Usually, patients are given a set of instructions to self-adjust their insulin dose. But doctors said most of the time, patients are reluctant to do so.
Dr Bee Yong Mong, director of the Diabetes Centre at Singapore General Hospital, said: "They lack the self-confidence of adjusting the doses, and there is a fear of getting a low blood glucose level, hence they often rely on the doctors or nurses to adjust the doses.
"They end up having a long duration of exposure to high glucose levels, which may in the long run, leads to more diabetes-related complications."
To study if the app can help patients achieve good glycaemic control, SGH and Duke-NUS Graduate Medical School are conducting a study to determine its effectiveness. This is the first such clinical trial involving mobile apps in a hospital setting.